21550-08-3

Basic information

• Product Name: m-Chlorobutyrophenone
• Synonyms: 1-(3-Chlorophenyl)butan-1-one;m-Chlorobutyrophenone
• CAS NO: 21550-08-3
• Molecular Formula: C₁₀H₁₁ClO
• Molecular Weight: 183
• Mol File: 21550-08-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 270℃
• Flash Point: 139℃
• Appearance: /
• Density: 1.100
• CAS DataBase Reference: m-Chlorobutyrophenone(CAS DataBase Reference)
• NIST Chemistry Reference: m-Chlorobutyrophenone(21550-08-3)
• EPA Substance Registry System: m-Chlorobutyrophenone(21550-08-3)

Safety Data

• Hazardous Substances Data: 21550-08-3(Hazardous Substances Data)

Usage

General Description

m-Chlorobutyrophenone is a chemical compound with the molecular formula C10H11ClO. It is a white crystalline solid, and is classified as a chlorinated aromatic ketone. m-Chlorobutyrophenone has been studied for its potential pharmaceutical properties, including as an antipsychotic and anesthetic agent. In addition, it has been investigated for its use in the synthesis of other organic compounds. m-Chlorobutyrophenone has also been identified as a potential intermediate in the production of other chemicals, and has been the subject of research into its environmental and toxicological properties. Overall, m-Chlorobutyrophenone has potential applications in the pharmaceutical and chemical industries and has been the focus of ongoing scientific investigation.

Upstream product

• 766-84-7 3-chloro-benzonitrile 
• 535-80-8 3-chlorobenzoate 
• 2234-82-4 1-propylmagnesium chloride 
• 24344-58-9 tributyl(3-chlorophenyl)stannane 
• 141-75-3 butyryl chloride 
• 1422446-29-4 C₂₀H₂₆Cl₂Sn 
• 927-77-5 n-propylmagnesium bromide 
• 145959-21-3 3-chloro-N-methoxy-N-methylbenzamide 

Downstream Products

• 1049971-92-7 2-(N-tert-butylamino)-3'-chlorobutyrophenone 
• 90844-66-9 2-bromo-3'-chlorobutanophenone 
• 51089-99-7 1-(3-chlorophenyl)butan-1-amine 
• 880473-86-9 1-(5-chloro-2-nitrophenyl)butan-1-one 
• 1231952-08-1 (Z)-tert-butyl(1-(3-chlorophenyl)but-1-enyloxy)dimethylsilane 
• 1428229-03-1 C₁₄H₁₅ClN₂O₂ 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

MONOAM1NE REUPTAKE INHIBITORS

The invention provides bupropion analogue compounds capable of inhibiting the reuptake of one or more monoamines. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine,and serotonin. Such compounds may be used to treat conditions that are responsive to inhibition of the reuptake of monoamines, including addiction, depression, and obesity

Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives

Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.